222

LAEKNA INC

No trades
See on Supercharts

2105 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Laekna, Inc. engages in the clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

2105 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company